Probe Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-06-2024
- Paid Up Capital ₹ 1.00 M
as on 16-06-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.57 Cr
as on 16-06-2024
- Revenue 32.95%
(FY 2023)
- Profit 64.59%
(FY 2023)
- Ebitda 33.67%
(FY 2023)
- Net Worth 15.23%
(FY 2023)
- Total Assets 20.39%
(FY 2023)
About Probe Diagnostic
The Corporate was formerly known as Probe Diagnostic & Rearch Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.57 Cr.
Anindita Nandi, Tanmay Nandi, Gopal Ray, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195WB1999PTC089683
- Company No.
089683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Probe Diagnostic?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anindita Nandi  | Director | 22-Jun-1999 | Current |
| Tanmay Nandi | Director | 20-Dec-2000 | Current |
| Gopal Ray | Director | 22-Jun-1999 | Current |
| Bipul Sain | Director | 01-Jan-2010 | Current |
Financial Performance of Probe Diagnostic.
Probe Diagnostic Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.95% increase. The company also saw a substantial improvement in profitability, with a 64.59% increase in profit. The company's net worth Soared by an impressive increase of 15.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Probe Diagnostic?
In 2023, Probe Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Apr 2022 | ₹7.46 M | Open |
Others Creation Date: 29 Sep 2017 | ₹2.00 M | Open |
Bank Of India Creation Date: 24 Jun 2014 | ₹5.50 M | Open |
How Many Employees Work at Probe Diagnostic?
Probe Diagnostic has a workforce of 88 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Probe Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Probe Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
